Detailed Office Action
Notice of Pre-AIA or AIA Status
1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Acknowledgement of Elections
2. Applicants’ election of Group I, claims 1-8, without traverse, in response to the Restriction Requirement, within the response of 13 February 2026 is acknowledged. Claims 9-12 have been withdrawn from further consideration as being drawn to a non-elected invention.
3. Applicants’ election of Species (IV), without traverse, in response to Election of Species Requirement I, within the response of 13 February 2026 is acknowledged. Species (IV) has been examined on the merits and found allowable; in accordance with Office practice, the examiner has therefore further examined Species (I). Claims 3, 4, 7, and 8 are withdrawn from further consideration as being drawn to non-elected species.
4. It is noted that applicants have not addressed Election of Species Requirement II. The examiner assumes this action was taken in view of applicants’ election of claims 1-8, to which Election of Species Requirement II does not apply.
Prior Art Rejection
5. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
6. Claims 1 and 5 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by CN 114957654 A.
CN 114957654 A discloses within the reaction scheme on page 8 of the reference a compound that corresponds to applicants’ claimed [Chemical Formula 1] having the chemical structures of [Chemical Formula 1-3].
Allowable Subject Matter
7. With regard to elected species (IV), claims 1 and 5 are allowable. With respect to Elected Species (IV) and Species (I), claims 2 and 6 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims and including only limitations with respect to the examined species.
8. CN 114957654 A fails to disclose compounds corresponding to Species (IV) and fails to disclose compounds corresponding to Species (I) having the claimed hydroxyl substituent ring location.
Conclusion
9. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Rabon A Sergent whose telephone number is (571)272-1079. The examiner can normally be reached on Monday through Friday from 9:00 AM until 5:00 PM, ET.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Riviere Kelley, can be reached at telephone number 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from Patent Center. Status information for published applications may be obtained from Patent Center. Status information for unpublished applications is available through Patent Center to authorized users only. Should you have questions about access to the USPTO patent electronic filing system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free).
Examiner interviews are available via a variety of formats. See MPEP § 713.01. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) Form at https://www.uspto.gov/InterviewPractice.
/RABON A SERGENT/Primary Examiner, Art Unit 1765